Marksans Pharma Ltd
NSE:MARKSANS

Watchlist Manager
Marksans Pharma Ltd Logo
Marksans Pharma Ltd
NSE:MARKSANS
Watchlist
Price: 293.7 INR -0.02%
Market Cap: 133.1B INR
Have any thoughts about
Marksans Pharma Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Marksans Pharma Ltd

Current Assets 20.8B
Cash & Short-Term Investments 6.8B
Receivables 5.7B
Other Current Assets 8.3B
Non-Current Assets 8.3B
PP&E 6.9B
Intangibles 1.1B
Other Non-Current Assets 344m
Current Liabilities 4.4B
Accounts Payable 2.8B
Short-Term Debt 240.4m
Other Current Liabilities 1.4B
Non-Current Liabilities 1.9B
Long-Term Debt 1.6B
Other Non-Current Liabilities 306.4m

Balance Sheet
Marksans Pharma Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
138
1 495
350
250
397
329
931
516
2 064
3 824
Cash
138
1 495
350
250
397
329
931
516
1 567
875
Cash Equivalents
0
0
0
0
0
0
0
0
497
2 949
Short-Term Investments
329
356
0
0
0
0
0
1 578
1 403
3 326
Total Receivables
1 934
1 935
2 371
2 685
1 826
1 836
2 434
2 714
3 978
4 195
Accounts Receivables
1 696
1 835
2 173
2 476
1 769
1 766
2 434
2 714
3 948
4 168
Other Receivables
238
100
198
209
57
70
0
0
30
26
Inventory
1 026
1 301
1 678
1 901
2 181
2 932
2 418
4 043
4 244
4 847
Other Current Assets
2
2
4
2
101
217
153
172
322
560
Total Current Assets
3 429
5 088
4 402
4 839
4 505
5 314
5 936
9 023
12 012
16 753
PP&E Net
725
1 024
1 641
1 649
1 864
1 981
2 300
2 540
3 423
3 869
PP&E Gross
725
1 024
1 641
1 649
1 864
1 981
2 300
2 540
3 423
3 869
Accumulated Depreciation
563
617
748
890
1 032
1 149
1 331
1 564
2 044
2 363
Intangible Assets
420
352
276
328
313
402
483
474
586
708
Goodwill
311
283
779
697
617
314
244
196
300
385
Note Receivable
15
8
101
6
8
13
33
26
26
43
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
15
12
31
24
54
146
Other Assets
311
283
779
697
617
314
244
196
300
385
Total Assets
4 901
N/A
6 756
+38%
7 200
+7%
7 518
+4%
7 322
-3%
8 037
+10%
9 027
+12%
12 283
+36%
16 401
+34%
21 904
+34%
Liabilities
Accounts Payable
832
1 070
1 190
1 618
778
1 061
1 103
1 687
2 001
2 306
Accrued Liabilities
0
0
0
0
72
72
72
89
110
104
Short-Term Debt
1 055
822
879
1 097
1 174
999
188
187
413
416
Current Portion of Long-Term Debt
344
64
0
0
5
3
33
60
281
157
Other Current Liabilities
960
906
442
246
317
191
891
961
758
427
Total Current Liabilities
3 191
2 862
2 511
2 961
2 347
2 326
2 288
2 984
3 562
3 410
Long-Term Debt
198
0
125
110
100
100
125
143
414
657
Deferred Income Tax
23
15
24
41
60
70
108
81
176
154
Minority Interest
66
81
84
62
95
102
131
189
207
199
Other Liabilities
0
0
7
10
11
14
15
21
19
33
Total Liabilities
3 479
N/A
2 958
-15%
2 751
-7%
3 184
+16%
2 613
-18%
2 612
0%
2 667
+2%
3 418
+28%
4 378
+28%
4 452
+2%
Equity
Common Stock
520
534
409
409
409
409
409
409
409
453
Retained Earnings
519
1 622
2 258
2 176
2 482
3 202
4 074
6 572
9 247
11 055
Additional Paid In Capital
463
1 751
1 751
1 751
1 751
1 751
1 751
1 751
1 732
5 045
Other Equity
80
110
30
2
66
62
126
133
635
898
Total Equity
1 422
N/A
3 798
+167%
4 449
+17%
4 334
-3%
4 709
+9%
5 425
+15%
6 360
+17%
8 865
+39%
12 023
+36%
17 452
+45%
Total Liabilities & Equity
4 901
N/A
6 756
+38%
7 200
+7%
7 518
+4%
7 322
-3%
8 037
+10%
9 027
+12%
12 283
+36%
16 401
+34%
21 904
+34%
Shares Outstanding
Common Shares Outstanding
385
409
409
409
409
409
409
409
409
453
Preferred Shares Outstanding
1
1
0
0
0
0
0
0
0
0

See Also

Discover More